Corvidia

About:

Corvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases.

Website: http://corvidiatx.com/

Top Investors: Andera Partners, Cormorant Asset Management, Fresenius Medical Care, Apple Tree Partners, Venrock

Description:

Corvidia Therapeutics is a clinical stage company focused on the research, development, and commercialization of transformative therapies for cardio-renal diseases. The Company is currently developing potential treatments for chronic kidney disease with atherosclerotic cardiovascular disease and inflammation, and high triglyceride-induced acute pancreatitis.

Total Funding Amount:

$86.8M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)corvidiatx.com

Founders:

Matt Devalaraja, Michael Davidson, Rahul Kakkar, Ram Aiyar

Number of Employees:

11-50

Last Funding Date:

2020-03-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai